These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21637751)

  • 1. Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.
    Hida K; Lai SK; Suk JS; Won SY; Boyle MP; Hanes J
    PLoS One; 2011; 6(5):e19919. PubMed ID: 21637751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors.
    Schuster BS; Kim AJ; Kays JC; Kanzawa MM; Guggino WB; Boyle MP; Rowe SM; Muzyczka N; Suk JS; Hanes J
    Mol Ther; 2014 Aug; 22(8):1484-1493. PubMed ID: 24869933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.
    Suk JS; Lai SK; Boylan NJ; Dawson MR; Boyle MP; Hanes J
    Nanomedicine (Lond); 2011 Feb; 6(2):365-75. PubMed ID: 21385138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.
    Suk JS; Boylan NJ; Trehan K; Tang BC; Schneider CS; Lin JM; Boyle MP; Zeitlin PL; Lai SK; Cooper MJ; Hanes J
    Mol Ther; 2011 Nov; 19(11):1981-9. PubMed ID: 21829177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
    White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
    Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mucus Barrier to Inhaled Gene Therapy.
    Duncan GA; Jung J; Hanes J; Suk JS
    Mol Ther; 2016 Dec; 24(12):2043-2053. PubMed ID: 27646604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells.
    Perricone MA; Rees DD; Sacks CR; Smith KA; Kaplan JM; St George JA
    Hum Gene Ther; 2000 Sep; 11(14):1997-2008. PubMed ID: 11020799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.
    Suk JS; Lai SK; Wang YY; Ensign LM; Zeitlin PL; Boyle MP; Hanes J
    Biomaterials; 2009 May; 30(13):2591-7. PubMed ID: 19176245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.
    Halbert CL; Miller AD; McNamara S; Emerson J; Gibson RL; Ramsey B; Aitken ML
    Hum Gene Ther; 2006 Apr; 17(4):440-7. PubMed ID: 16610931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport.
    Dawson M; Wirtz D; Hanes J
    J Biol Chem; 2003 Dec; 278(50):50393-401. PubMed ID: 13679362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression from adeno-associated virus vectors in airway epithelial cells.
    Flotte TR; Solow R; Owens RA; Afione S; Zeitlin PL; Carter BJ
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):349-56. PubMed ID: 1325813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
    Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
    Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.
    Guggino WB; Cebotaru L
    Expert Opin Biol Ther; 2017 Oct; 17(10):1265-1273. PubMed ID: 28657358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.
    Broughton-Head VJ; Smith JR; Shur J; Shute JK
    Pulm Pharmacol Ther; 2007; 20(6):708-17. PubMed ID: 17055310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
    Flotte TR
    Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for cystic fibrosis.
    Flotte TR
    Curr Opin Mol Ther; 1999 Aug; 1(4):510-6. PubMed ID: 11713767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
    Guggino WB; Cebotaru L
    Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
    Tang BC; Dawson M; Lai SK; Wang YY; Suk JS; Yang M; Zeitlin P; Boyle MP; Fu J; Hanes J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19268-73. PubMed ID: 19901335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors.
    Enger PØ; Thorsen F; Lønning PE; Bjerkvig R; Hoover F
    Hum Gene Ther; 2002 Jun; 13(9):1115-25. PubMed ID: 12067444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.